Drug
Fluticasone Furoate Nasal Spray
Fluticasone Furoate Nasal Spray: highest development phase Post-Market, developed by GlaxoSmithKline. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| fluticasone furoate nasal spray NCT00682643 | Post-Market | Rhinitis, Allergic, Perennial |
Latest
No recent events.
Follow Fluticasone Furoate Nasal Spray on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.